X-linked hypophosphatemia
X-linked hypophosphatemia | |
---|---|
Other names | X-linked dominant hypophosphatemic rickets, or X-linked Vitamin D-resistant rickets, X-linked dominant manner. |
Specialty | Endocrinology, pediatrics |
Complications | osteomalacia (adults), rickets (children), fractures, enthesopathy, spinal stenosis, abnormal gait, short stature, tinnitus, hearing loss, dental complications, in rare exceptions Chiari malformation can occur. |
Causes | A genetic mutation of the PHEX gene results in elevated FGF23 hormone. |
Medication | phosphate, vitamin-D or burosumab |
X-linked hypophosphatemia (XLH) is an
For both XLH and hypophosphatasia, inhibitor-enzyme pair relationships function to regulate mineralization in the extracellular matrix through a double-negative (inhibiting the inhibitors) activation effect in a manner described as the Stenciling Principle.[8][9] Both these underlying mechanisms (renal phosphate wasting systemically, and mineralization inhibitor accumulation locally) contribute to the pathophysiology of XLH that leads to soft bones and teeth (hypomineralization, osteomalacia/odontomalacia).[10][11][12] The prevalence of the disease is 1 in 20,000.[13]
X-linked hypophosphatemia may be lumped in with autosomal dominant hypophosphatemic rickets under general terms such as hypophosphatemic rickets. Hypophosphatemic rickets are associated with at least nine other genetic mutations.[14] Clinical management of hypophosphatemic rickets may differ depending on the specific mutations associated with an individual case, but treatments are aimed at raising phosphate levels to promote normal bone formation.[15]
Symptoms and signs
The most common symptoms of XLH affect the bones and teeth, causing pain, abnormalities, and osteoarthritis. Symptoms and signs can vary between children and adults and can include:
Children
Adults
- Osteomalacia[16]
- Dental abscesses[20]
- Limited range of movement (enthesopathy)[20] [21]
- Short stature[20]
- Fatigue[19]
- Fractures / pseudofracture[22]
- Bone pain[18] People often have bowed legs or knock knees in which they usually cannot touch both knees and ankles together at the same time.[citation needed]
- Craniostenosis[20]
- Osteoarthritis[23]
- Spinal stenosis[24]
- Hearing loss[20]
- Depression[25]
- Impaired innate immunity[26]
- Defective mineral tessellation (an ultrastructural mineralization deficiency)[27] [28]
Genetics
XLH affects about 1:20,000 individuals and is the most common cause of inherited phosphate wasting.[26]
It is associated with a mutation in the PHEX gene sequence, located on the human X chromosome at location Xp22.2-p22.1.[1][2][29] The PHEX protein regulates another protein called fibroblast growth factor 23 (produced from the FGF23 gene). Fibroblast growth factor 23 normally inhibits the kidneys' ability to reabsorb phosphate into the bloodstream. Gene mutations in PHEX prevent it from correctly regulating fibroblast growth factor 23. The overactivity of FGF-23 reduces vitamin D 1α-hydroxylation and phosphate reabsorption by the kidneys, leading to hypophosphatemia and the related features of ricket.[30] Also in XLH, where PHEX enzymatic activity is absent or reduced, osteopontin[31]—a mineralization-inhibiting secreted substrate protein found in the extracellular matrix of bone[32]—accumulates in bone (and teeth) to contribute to the osteomalacia (and odontomalacia) as shown in the mouse homolog (Hyp) of XLH and in XLH patients.[33][34][35]
The disorder is inherited in an
As the X chromosome is one of the sex chromosomes (the other being the Y chromosome), X-linked inheritance is determined by the sex of the parent carrying a specific gene and can often seem complex. This is because, typically, females have two copies of the X-chromosome and males have only one copy. The difference between dominant and recessive inheritance patterns also plays a role in determining the chances of a child inheriting an X-linked disorder from their parentage.[citation needed]
Diagnosis
The clinical laboratory evaluation of rickets begins with assessment of serum calcium, phosphate, and alkaline phosphatase levels. In hypophosphatemic rickets, calcium levels may be within or slightly below the reference range; alkaline phosphatase levels will be significantly above the reference range.Biochemically, XLH is recognized by hypophosphatemia.[36]
Carefully evaluate serum phosphate levels in the first year of life, because the concentration reference range for infants (5.0–7.5 mg/dL) is high compared with that for adults (2.7–4.5 mg/dL).[citation needed]
Serum parathyroid hormone levels are within the reference range or slightly elevated. calcitriol (1,25-(OH)2 vitamin D3) levels are low or within the lower reference range. Most importantly, urinary loss of phosphate is above the reference range.[citation needed]
The renal tubular reabsorption of phosphate (TRP) in X-linked hypophosphatemia is 60%; normal TRP exceeds 90% at the same reduced plasma phosphate concentration. The TRP is calculated with the following formula:[citation needed]
- 1 − [Phosphate Clearance (CPi) / Creatinine Clearance (Ccr)] × 100
Treatment
Conventional therapy consisted of medications including
In February 2018 the European Medicines Agency first licensed a monoclonal antibody directed against FGF23, the first drug targeting the underlying cause for this condition,[39] called burosumab.[40] It was then licensed by the US Food and Drug Administration in June 2018[41]
The leg deformity can be treated with
In the event of severe bowing, an osteotomy can be performed to correct the leg shape.[42]Society and culture
International XLH Alliance – an alliance of international patient groups for individuals affected by XLH and related disorders.
See also
- Autosomal dominant hypophosphatemic rickets
- Hypophosphatemia
- Tumor-induced osteomalacia
References
- ^ a b c Rasmussen SA, McKusick VA (June 23, 2023) [Originally published June 4, 1986], "HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR", Online Mendelian Inheritance in Man, Johns Hopkins University 307800
- ^ PMID 19581284.
- PMID 25905395. National Library of Medicine Bookshelf ID NBK279172.
- S2CID 20840491.
- PMID 27884786.
- PMID 27884786.
- S2CID 20840491.
- S2CID 218909350.
- S2CID 245187449.
- S2CID 245187449.
- PMID 23931057.
- S2CID 221164596.
- PMID 9130929.
- ^ Online Mendelian Inheritance in Man (OMIM): 193100
- ^ "Hypophosphatemic rickets". Genetic and Rare Diseases Information Center. National Institutes of Health. Archived from the original on June 12, 2012. Retrieved October 10, 2012.
- ^ a b "Osteomalacia and Rickets". The Lecturio Medical Concept Library. Retrieved August 24, 2021.
- ^ Silva, Sandra; Jeanty, Philippe (June 7, 1999). "Cloverleaf skull or kleeblattschadel". TheFetus.net. MacroMedia. Archived from the original on January 7, 2007. Retrieved February 3, 2007.
- ^ a b Luger, N. Mach, D. Sevcik, M. Mantyh, P. (2005). Bone cancer pain: From mechanism to model to therapy. Journal of Pain and Symptom Management. 29(5): 32-46.
- ^ a b "Fatigue". MedlinePlus. Retrieved April 30, 2020.
- ^ PMID 24550322.
- S2CID 259131061.
- ^ "Overview of Bone Fractures". The Lecturio Medical Concept Library. Retrieved August 24, 2021.
- ^ "Osteoarthritis". The Lecturio Medical Concept Library. Retrieved August 24, 2021.
- PMID 31259293.
- PMID 33331900.
- ^ PMID 30808384.
- S2CID 221164596.
- S2CID 259131061.
- ^ Rasmussen SA, Kniffin CL (October 17, 2023) [Originally published July 28, 2005], "PHOSPHATE-REGULATING ENDOPEPTIDASE HOMOLOG, X-LINKED; PHEX", Online Mendelian Inheritance in Man, Johns Hopkins University 300550
- S2CID 20559055.
- PMID 11021631.
- S2CID 40705942.
- PMID 23931057.
- PMID 27884786.
- PMID 22991293.
- PMID 31068690.
- ^ PMID 20157195.
- ^ PMID 6252463.
- S2CID 44135503.
- ^ "EMA authorisation details". September 17, 2018.
- ^ "FDA press release".
- ^ a b "X-linked hypophosphatemia | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved October 21, 2018.